Nom du produit:tert-Butyl 7-chloro-5-oxo-2,3-dihydroimidazo[1,2-c]pyrimidine-1(5H)-carboxylate
IUPAC Name:tert-butyl 7-chloro-5-oxo-1H,2H,3H,5H-imidazo[1,2-c]pyrimidine-1-carboxylate
- CAS：1421433-88-6
- Formule moléculaire：C11H14ClN3O3
- Pureté：95%
- Numéro de catalogue：CM321640
- Poids moléculaire：271.7
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:1421433-88-6
- Formule moléculaire:C11H14ClN3O3
- Point de fusion:-
- Code SMILES:O=C(N1CCN(C1=CC(Cl)=N2)C2=O)OC(C)(C)C
- Densité:
- Numéro de catalogue:CM321640
- Poids moléculaire:271.7
- Point d'ébullition:
- N° Mdl:MFCD25542339
- Stockage:
Category Infos
- Pyrimidines
- Pyrimidine, also known as 1,3-diazobenzene, is a heterocyclic compound with the chemical formula C4H4N2. Pyrimidine is formed by substituting 2 nitrogen atoms for 2 carbons in the meta-position of benzene. It is a diazine and retains its aromaticity. Derivatives of pyrimidine widely exist in organic macromolecular nucleic acids, and many drugs also contain pyrimidine rings. In nucleic acids, three nucleobases are pyrimidine derivatives: cytosine, thymine and uracil. There are a variety of pyrimidine-containing drugs on the market, most of which are kinase inhibitors.
- Imidazolidines
- Imidazolidine is a heterocyclic compound (CH2)2(NH)2CH2. The parental imidazolidines are less studied, but related compounds substituted on one or both nitrogen centers are more common. Generally, they are colorless, polar, basic compounds. Imidazolidines are examples of cyclic 5-membered general amines. Imidazolidine derivatives are key components in the development of bioactive compounds for the treatment of various diseases, especially Chagas disease. In fact, other studies have shown that imidazoline-2,4-diones have a wide range of pharmacological activities, including anticonvulsant, antiarrhythmic, and antiparasitic.
- imidazolidine supplier
- As a imidazolidine supplier,we sincerely welcome the new and old friends from home and abroad to synergize with our company and share the benefits and opportunities.
Recherche 
+86 21 5895 0110 
